Commitment COM-309
Post-approval commitment for SwissMedic-2021-0009. Category: Post-Approval Study. Priority: high.
Commitment ID
COM-309
Application
Authority
Swissmedic
Category
Post-Approval Study
Priority
high
Status
Blocked
Due Date
2025-12-08
Completed At
—
Owner
Sarah Chen
Created
2022-10-15
Description
Provide confirmatory bioequivalence study for 200 mg strength
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.